ASCIA e-training SCEC: About ASCIA anaphylaxis e-training

About ASCIA anaphylaxis e-training

Courses Updated 15 January 2024

ASCIA anaphylaxis e-training courses for schools and cec have been updated in January 2024 (Version 9.0 still as course refreshed only as no content changed required):

Courses for 2024 are as follows:

Enrol For Australia or New Zealand: ASCIA Anaphylaxis refresher e-training

This course should only be used for interim refresher training and does not replace the comprehensive ASCIA anaphylaxis e-training courses for schools, children's education/care, community and health professionals. Undertake every 6 months. Takes less than 20 minutes to complete.

Courses Updated 21 January 2023 now superseded

ASCIA anaphylaxis e-training courses for schools and cec have been updated in January 2023 (Version 9.0):

Minor formatting changes only.
As of September 2022, the time for Anapen® adrenaline (epinephrine) autoinjectors to be held in place has now been approved for 3 seconds (reduced from 10 seconds) by the Therapeutic Goods Administration (TGA).
Completion of anonymous Feedback required to gain a Certificate of Completion that confirms successful course completion, which requires participants to obtain 100% for the Final Assessment

Courses Updated 1 September 2022 now superseded

ASCIA anaphylaxis e-training courses for schools and cec have been updated in September (Version 8.0) to include the following:

Updated and new ASCIA Action and First Aid Plans.
New infographics and animations to make the training more visual and interactive.
Instructions for two brands of adrenaline (epinephrine) injectors, EpiPen® and Anapen® (available on the PBS September 2021).
A certificate that confirms successful course completion, which requires participants to obtain 100% for the Final Assessment or Quiz.

Courses for 2021-2 were as follows:

Access For Australia or New Zealand: ASCIA anaphylaxis e-training: Australasian schools 2021-2

Access For Queensland: ASCIA anaphylaxis: Queensland schools 2021-2

Access For Australia or New Zealand: ASCIA anaphylaxis e-training: Australasian children's education/care 2021-2

Accreditation

ASCIA anaphylaxis e-training for Children’s Education/Care (CEC) is a nationally approved qualification by the Australian Children's Education and Care Quality Authority (ACECQA) for anaphylaxis management training under the National Quality Framework (NQF).

ASCIA anaphylaxis e-training courses for schools and children's education/care (cec) have been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body in Australasia for allergy and clinical immunology.

These courses were first developed by ASCIA in 2010, to provide ready access to reliable and consistent anaphylaxis education throughout Australia and New Zealand, at no charge.

Development and regular updating of ASCIA anaphylaxis e-training requires extensive review and consultation with ASCIA members as well as representatives from schools, ecec services, education departments, health departments and patient support organisations throughout Australasia.

ASCIA anaphylaxis e-training courses for schools and cec courses for 2023 are Version 9.0 with the following updates.

Minor formatting changes only.
As of September 2022, the time for Anapen® adrenaline (epinephrine) autoinjectors to be held in place has now been approved for 3 seconds (reduced from 10 seconds) by the Therapeutic Goods Administration (TGA).
Completion of anonymous Feedback required to gain a Certificate of Completion that confirms successful course completion, which requires participants to obtain 100% for the Final Assessment

8.0 changes included:

Updated and new ASCIA Action and First Aid Plans.
New infographics and animations to make the training more visual and interactive.
Instructions for two brands of adrenaline (epinephrine) injectors, EpiPen® and Anapen® (available on the PBS September 2021).
A certificate that confirms successful course completion, which requires participants to obtain 100% for the Final Assessment or Quiz.

7.0 changes included:

The weight range for adrenaline autoinjectors (150 mcg) has changed from 10-20kg to 7.5-20kg, to be consistent with ASCIA Guidelines and consensus expert opinion.
The section for the doctor or nurse practitioner to complete In the RED and GREEN plans is more detailed and clearer.
The ORANGE plan (used mostly as a poster) has a new title “ASCIA First Aid Plan for Anaphylaxis” and translated versions of this plan are available on the ASCIA website.

Course instructions:

A username and password must be obtained from the e-training website registration process to participate in a course.
Course participants should read each module carefully then complete the quiz. You must get each question correct before you can move onto the next module. Feedback will be provided after answering each question correctly.
Modules may only be completed in order.
Upon successful completion of the course (by achieving at least 100% in the final assessment module quiz) each participant will have access to a Certificate of Completion. The certificate is available as a PDF file for print or saving as required. Each certificate contains a unique QR code that verifies the course participant and result.
It is recommended the modules are completed within a two week period.

Example of certificate

Certificate example